Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis.
Elio Gregory PizzutiloMartino PedraniAlessio AmatuLorenzo RuggieriCalogero LauricellaSilvio Marco VeroneseDiego SignorelliGiulio CereaLaura GiannettaSalvatore SienaAndrea Sartore-BianchiPublished in: Cancers (2021)
While dedicated trials are needed, LB holds potential clinical roles in both de novo and transformed SCLC. CtDNA analysis appears the most valuable and practicable tool for both disease monitoring and genomic profiling.